Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral lactase for feeding tolerance and growth in very preterm infants
ChiCTR2300076218Phase 4Not yet recruiting
- Sponsor
- Peking University Shenzhen Hospital
- Start
- Oct 2023
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of lactase in feeding intolerance (2 arms), sponsored by Peking University Shenzhen Hospital. Primary endpoint: Incidence of feeding intolerance. Planned start Oct 2023; status: not yet recruiting.
02
Drugs
lactase
03
Conditions
feeding intolerance
Beyond the preview
Go deeper on ChiCTR2300076218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300076218.